Abstract
Sleep-related hallucinations are a type of perceptual experience that occurs during transition to sleep or at awakening and can be of any sensory modality. Hypnagogic hallucinations occur at sleep onset while hypnopompic hallucinations occur at awakening. Nocturnal hallucinations have been reported in normal individuals, however, they occur more frequently in patients with various clinical conditions, especially in narcolepsy. Evaluation of sleep-related hallucinations involves comprehensive clinical assessment with laboratory investigations when other neurological or sleep disorders are suspected. There is no specific treatment for sleep-related hallucinations. In most uncomplicated cases they resolve with reassurance. Management of underlying causes of hallucinations is usually effective in reducing their frequency and intensity.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Mahowald MW, Woods SR, Schenck CH. Sleeping dreams, waking hallucinations, and the central nervous system. Dreaming. 1998;8:89–102.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th ed. Washington, DC: American Psychiatric Association; 2000.
Ohanyon MM, Schatzberg AF. Prevalence of depressive episodes with psychotic features in the general population. Am J Psychiatry. 2002;159:1855–61.
Pope HG, Lipinski JF. Diagnosis of schizophrenia and manic-depressive illness. A reassessment of the specificity of “schizophrenic” symptoms in the light of current research. Arch Gen Psychiatry.1978;35:811–28.
Keck PE, McElroy SL, Havens JR, et al. Psychosis in bipolar disorder: phenomenology and impact on morbidity and course of illness. Compr Psychiatry. 2003;44:263–69.
Thanvi BR, Lo TC, Harsh DP. Psychosis in Parkinson’s disease. Postgrad Med J. 2005;81:644–46.
Lyketsos CG, Steinberg M, Tschanz JT, et al. Mental and behavioral disturbances in dementia: findings from the Cache County study on memory in aging. Am J Psychiatry. 2000;157:708–14.
Sartorius N, Shapiro R, Jablensky A. The international pilot study of Sch. Sch Bulletin. 1974;11:21–34.
Tien AY. Distributions of hallucinations in the population. Soc Psychiatry Psychiatr Epidemiol. 1991;26:287–92.
Posey TB, Losch ME. Auditory hallucinations of hearing voices in 375 normal subjects. Imag Cogn Pers. 1984;3:99–113.
Bentall RP, Slade PD. Reality testing and auditory hallucinations: a signal detection analysis. Br J Clin Psychol. 1985;24:159–69.
Young HF, Bentall RP, Slade PD, et al. Disposition towards hallucinations, gender and IQ scores. Pers Invivid Dif. 1986;7:247–49.
Millham A, Easton S. Prevalence of auditory hallucinations in nurses in mental health. J Psychiatr Ment Health Nurs. 1998;5:95–9.
García-Ptacek S, García Azorín D, Sanchez Salmador R, Cuadrado ML, Porta-Etessam J. Hallucinations and aberrant perceptions are prevalent among the young healthy adult population. Neurologia. 2013 Jan-Feb;28(1):19–23.
Honig A, Romme MA, Ensink BJ, et al. Auditory hallucinations: a comparison between patients and nonpatients. J Nerv Ment Dis. 1998;186:646–51.
Johns L, Hemsley D, Kuipers E. A comparison of auditory hallucinations in a psychiatric and non-psychiatric group. Br J Clin Psychol. 2002;41:81–6.
Maury LF. Des hallucinations hypnagogiques (in French). Ann Med Psychol (Paris). 1848;11:26–40.
Myers FW. Sleep, human personality and its survival of bodily death. New York: NY Longman; 1903. p. 125.
Ohayon MM. Prevalence of hallucinations and their pathological associations in the general population. Psychiatry Res. 2000;97:153–64.
Ohayon MM, Priest RG, Caulet M, Guilleminault C. Hypnagogic and hypnopompic hallucinations: pathological phenomenon? Br J Psychiatry. 1996;169:459–67.
Mavormatis A. Hypnagogia—the unique state of consciousness between wakefulness and sleep:. London: Routledge & Kegan Paul; 1987.
Manford M, Andermann F. Complex visual hallucinations. Clinical and neurobiological insights. Brain. 1998;121 (Pt 10):1819–40.
Silber MH, Hansen MR, Girish M. Complex nocturnal visual hallucinations. Sleep Med. 2005;6(4):363–6
Goetz M, Prihodova I, Hrdlicka M. Long lasting complex nocturnal hallucinations during Osmotic Release Oral System (OROS) methylphenidate treatment in a 7-year old girl. Neuro Endocrinol Lett. 2011;32(5):619–22.
Goswami M. The influence of clinical symptoms on quality of life in patients with narcolepsy. Neurology. 1998;50(2 Suppl 1):31–36.
Dahmen N, Kasten M, Mittag K, Muller MJ. Narcoleptic and schizophrenic hallucinations. Implications for differential diagnosis and pathophysiology. Eur J Health Econ. 2002;3(suppl 2):94–98.
Fortuyn HAD, Lappenschaar GA, Nienhuis FJ, Furer JW, et al. Psychotic symptoms in narcolepsy: phenomenology and comparison with schizophrenia. Gen Hosp Psychiatry. 2009;31:146–54.
Leu-Semenescu S, De Cock VC, Le Masson VD, Debs R, Lavault S, Roze E, Vidailhet M, Arnulf I. Hallucinations in narcolepsy with and without cataplexy: contrasts with Parkinson’s disease. Sleep Med. 2011;12(5):497–504.
Yasui-Furukori N, Kusunoki M, Kaneko S. Hallucinations associated with modafinil treatment for narcolepsy. J Clin Psychopharmacol. 2009;29(4):408.
Hsieh CF, Lai CL, Lan SH, Liu CK, Hsu CY. Modafinil-associated vivid visual hallucination in a patient with Kleine-Levin syndrome: case report. J Clin Psychopharmacol. 2010;30(3):347–50.
Prado E, Paholpak P, Ngo M, Porter V, Apostolova LG, Marrocos R, Ringman JM. Agitation and psychosis associated with dementia with Lewy bodies exacerbated by modafinil use. Am J Alzheimers Dis Other Demen. 2012;27(7):468–73.
Toner LC, Tsambiras BM, Catalano G et al. Central nervous system side effects associated with zolpidem treatment. Clin Neuropharmacol. 2000;23(1):54–8.
Inagaki T, Miyaoka T, Tsuji S, et al. Adverse reactions to zolpidem: a case reports and a review of the literature. Prim Care Companion J Clin Psychiatry. 2010;12(6):PCC.09r00849.
Elko CJ, Burgess JL, Robertson WO. Zolpidem-associated hallucinations and serotonin reuptake inhibition: a possible interaction. J Toxicol Clin Toxicol. 1998;36(3):195–203.
Bonnet C. Essai analytique sur les facultes d l’ame. Copenhagen:Philibert;1760.
Menon GJ, Rahman I, Menon SJ, Dutton GN. Complex visual hallucination in the visually impaired: the Charles Bonnet syndrome. Surv Opthalmol. 2003;48(1):58–72.
Kazui H, Ishii R, Yoshida T, Ikezawa K, Takaya M, Tokunaga H, Tanaka T, Takeda M. Neuroimaging studies in patients with Charles Bonnet Syndrome. Psychogeriatrics. 2009;9(2):77–84.
Teunisse RJ, Cruysberg JR, Hoefnagels WH, Verbeek AL, Zitman FG. Visual hallucinations in psychologically normal people: Charles Bonnet’s syndrome. Lancet. 1996 Mar 23;347(9004):794–7
Fénelon G, Alves G. Epidemiology of psychosis in Parkinson’s disease. J Neurol Sci. 2010;289(1–2):12–7.
Lhermitte J. Syndrome de la calotte du Pedoncule cerebral. Les troubles psycho-sensoriels dans les lesions du mésocéphale. Rev Neurol (Paris). 1922;2:1359–65.
Kumar R, Behari S, Wahi J, Banerji D, Sharma K. Peduncular hallucinosis: an unusual sequel to surgical intervention in the suprasellar region. Br J Neurosurg. 1999;13(5):500–3.
Parisis D, Poulios I, Karkavelas G, Drevelengas A, et al. Peduncular hallucinosis secondary to brainstem compression by cerebellar metastasis. Eur Neurol. 2003;50:107–9.
Mauguiere F. Scope and presumed mechanisms of hallucinations in partial epileptic seizures. Epileptic Disord. 1999;1:81–91.
Sowa MV, Pituck S. Prolonged spontaneous complex visual hallucinations and illusions as ictal phenomena. Epilepsia. 1989;30(5):524–6.
Waters WE, O’Connor PJ. Prevalence of migraine. J Neurol Neurosurg Psychiatry. 1975;38:613–6.
Russell MB, Olesen J. A nosographic analysis of the migraine aura in a general population. Brain. 1996;119:355–61.
Bliwise DL, Mercaldo ND, Avidan AY, Boeve BF, Greer SA, Kukull WA. Sleep disturbance in dementia with Lewy bodies and. Alzheimer’s disease: a multicenter analysis. Dement Geriatr Cogn Disord. 2011;31(3):239–46.
Sinforiani E, Terzaghi M, Pasotti C, Zucchella C, Zambrelli E, Manni R. Hallucinations and sleep-wake cycle in Alzheimer’s disease: a questionnaire-based study in 218 patients. Neurol Sci. 2007;28(2):96–9.
Mignot E, Nishino S. Emerging therapies in narcolepsy-cataplexy. Sleep. 2005;28(6):754–63.
Møller LR, Østergaard JR. Treatment with venlafaxine in six cases of children with narcolepsy and with cataplexy and hypnagogic hallucinations. J Child Adolesc Psychopharmacol. 2009;19(2):197–201.
Mamelak M, Black J, Montplasir J, Ristanovic RA. A pilot study on the effects of sodium oxybate on sleep architecture and daytime alertness in narcolepsy. Sleep. 2004;27:1327–34.
The US Xyrem multicenter study group. A randomized, double blind, placebo-controlled multicenter trial comparing the effects of the three doses of orally administered sodium oxybate with placebo for the treatment of narcolepsy. Sleep. 2002;25:42–9.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Ivanenko, A., Relia, S. (2013). Sleep-Related Hallucinations. In: Kothare, S., Ivanenko, A. (eds) Parasomnias. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-7627-6_14
Download citation
DOI: https://doi.org/10.1007/978-1-4614-7627-6_14
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-7626-9
Online ISBN: 978-1-4614-7627-6
eBook Packages: MedicineMedicine (R0)